| First, Background and PurposeNational Essential Drug System of China’s medical and health system as animportant reform on the national economy, is a new system to continuously improvethe health of the masses, the people meet the basic medical and medication needs, toachieve coverage of urban and rural residents basic health care system, and promoteuniversal access to basic health care to the overall goal. Has initially established anational essential drug-related institutional system, the provinces and theimplementation of national essential drug system has entered a phase of consolidationperfect. And consolidate and improve the procurement of essential drugs is the key anddifficult. This study will be health care reform plan as a guide, through communityhealth organizations in Jilin procurement of essential drugs to conduct research,combined with the general requirements of a new round of health care reform, summedup the experience of effective practice, while analysis to find the problems raisedbidding and procurement of essential drugs to improve the mechanism of measures tofurther establish and improve the essential drug procurement system, provide referenceproposal.Second, the research content and methods:1. Data Source: The data from the paper "Jilin Pharmaceutical ProcurementService Platform" pharmaceutical bidding system, collecting in2011and2014annualprimary health care institutions essential drugs centralized purchasing data, accordingto a different year, same area, different regions and the different product categories forcomparison analysis.2.10City, Jilin Province (state)25counties (cities, districts) of the primary healthcare institutions, based on sample of88primary health care institutions, a largenumber of interviews with the relevant officials and primary health care institutionsand experts and insiders belongs health, finance, social security and other departments,other provincial centralized procurement of essential drugs agencies, and pharmaceutical manufacturers and enterprises related personnel. Medical personnelwhile sampling healthcare facilities, inpatient and outpatient for the survey,questionnaire. Topics covered include primary health care institutions essential drugsvarieties with situations and people satisfaction. Analysis of the outstanding problemsin Jilin community health organizations working in drug procurement and supply, andput forward effective countermeasures and suggestions.Third, the conclusions and recommendationsEstablishment of national essential drug system, adhere to the basic principles of"basic, strong grass-roots, building mechanism". First clear use of primary health careinstitutions essential drugs is to adapt the basic health care needs, the dosage formsuitable, reasonable price, to protect the supply of equitable access to medicinesavailable to the public; at the same time, we also need to emphasize not only theprocurement of essential drugs supply chain, it also includes the selection,development, production, distribution, use, pricing, reimbursement, monitoring andevaluation, and even advertising other necessary aspects of management. To ensuresafe use of essential drugs grassroots timely supply, including the need to establish abasic drug production, procurement, use, storage and other essential drugs supplysystem.After a review of the literature in this paper, theoretical analysis and empiricalinvestigation, combined with the status quo of Jilin run primary health care institutions,integrated informant interviews, survey results and other provinces experience ofenlightenment, etc., in the primary health care institutions essential drug supply systemin Jilin Province, proposal should follow the following principles: governmentguidance and adhere to the market economy mechanism combining; adhere to standardmedicines market liquidity, optimize the integration of medical resources of ideas;insisted volume and price linked to the classification of online procurement, unifieddistribution patterns; persist provincial unified payments, improve the regulatorymechanism and reasonable guide therapy initiatives.Specific measures are:First, we must further improve the provincial centralized procurement of essentialdrugs mechanism, adhere to government guidance and market economy combined;The second is to do the essential drug list, the establishment of appropriatecomplementary mechanisms to meet the clinical needs; The third is to improve procurement, category management, reform the drugpricing mechanism;Fourth, information technology network, based on the establishment of aneffective regulatory mechanism of procurement and supply;Fifth, the circulation of essential drugs to achieve reform, the development ofmodern pharmaceutical logistics;Sixth, strengthen basic drugs in the guidance and evaluation. |